4D Molecular Therapeutics Funding & Investors
4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of California.
4dmoleculartherapeutics.comTotal Amount Raised: $295,000,000
4D Molecular Therapeutics Funding Rounds
Post Ipo Equity
$120,000,000
Series C
$75,000,000
Series C Investors
Cystic Fibrosis FoundationArrowMark PartnersPfizer Venture InvestmentsBiotechnology Value FundLongevity Vision FundAmzak Health InvestorsQUAD Investment ManagementRidgeback Capital ManagementViking Global InvestorsBerkeley Catalyst Fund (BCF)Pappas CapitalMirae AssetOctagon Capital AdvisorsPerceptive AdvisorsChiesi VenturesCasdin CapitalSeries B
$90,000,000
Series B Investors
Ridgeback Capital ManagementViking Global InvestorsBerkeley Catalyst Fund (BCF)Pappas CapitalPerceptive AdvisorsArrowMark PartnersPfizer Venture InvestmentsChiesi VenturesBiotechnology Value FundMirae AssetHenderson Global InvestorsCureDuchenneSeries Unknown
$3,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries Unknown
$6,999,995
Funding info provided by Diffbot.